-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Lexicon Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from 2010 to 2023.
- Lexicon Pharmaceuticals, Inc. Revenues for the quarter ending September 30, 2024 was $1.75M, a 980% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. Revenues for the twelve months ending September 30, 2024 was $5.23M.
- Lexicon Pharmaceuticals, Inc. annual Revenues for 2023 was $1.2M, a 766% increase from 2022.
- Lexicon Pharmaceuticals, Inc. annual Revenues for 2022 was $139K, a 53.4% decline from 2021.
- Lexicon Pharmaceuticals, Inc. annual Revenues for 2021 was $298K, a 98.8% decline from 2020.